COVID-19: Epidemiological considerations for re-opening Dr. Caroline - PowerPoint PPT Presentation

Jan 02, 2024 •405 likes •505 views

COVID-19: Epidemiological considerations for re-opening Dr. Caroline Buckee Associate Professor of Epidemiology, Associate Director of the Centre for Communicable Disease Dynamics, Harvard TH Chan School of Public Health

COVID-19: Epidemiological considerations for re-opening Dr. Caroline Buckee Associate Professor of Epidemiology, Associate Director of the Centre for Communicable Disease Dynamics, Harvard TH Chan School of Public Health cbuckee@hsph.harvard.edu, @Caroline_OF_B CarolineOB BROOKINGS, May 12 th 2020
Open question 1: immunity? Kissler et al (2020)
Open question 2: asymptomatics? Asymptomatic Prem et al. (2020) Lancet Preprint: Silverman et al (2020)
Open question 3: contact rates? Normal Under social distancing Prem et al. (2020) Lancet
covid19mobility.org
Considerations for re-opening • How will we monitor the epidemic while re-opening? • What will the decision-rule be for adapting policies? • The epidemic is hyper-local and staggered: what spatial scale is appropriate for policy making? • What are we willing to tolerate?

Recommend

COVID-19 Re-Opening Phase II: Employment May 28, 2020 Considerations Jeanine DeBacker

COVID-19 Re-Opening Phase II: Employment May 28, 2020 Considerations Jeanine DeBacker jdebacker@mstpartners.com https://calemploymentlawblog.com About Todays Webinar Schedule: 9:00- 9:45 Presentation overview of the issues

604 views • 31 slides

Clean Air Act: Important issues and considerations during COVID-19 COVID-19 Considerations

Clean Air Act: Important issues and considerations during COVID-19 COVID-19 Considerations Statements by the EPA and the DEQ Preparing your facility for compliance Documentation Redundancy planning Impacts to DEQ staffing

373 views • 13 slides

ESE Legal Considerations ESE Legal Considerations in Light of in Light of COVID COVID-19 19

ESE Legal Considerations ESE Legal Considerations in Light of in Light of COVID COVID-19 19 Julie Weatherly, Esq. Julie Weatherly, Esq. Resolutions in Special Education, Inc. Presentation to FADSS June 8, 2020 Disclaimer Disclaimers The

559 views • 36 slides

SCHOOL RE-ENTRY AT A GLANCE Health and Safety Plans COVID-19 CONSIDERATIONS COVID-19 RE-ENTRY

SCHOOL RE-ENTRY AT A GLANCE Health and Safety Plans COVID-19 CONSIDERATIONS COVID-19 RE-ENTRY CONSIDERATIONS Hand hygiene Masks Social Distancing (6 ft. apart) Cleaning procedures Food Services Infrastructure changes

370 views • 15 slides

August 14, 2020 COVID-19 Epidemiological Summary Content covered: Epidemic curves

August 14, 2020 COVID-19 Epidemiological Summary Content covered: Epidemic curves Syndromic surveillance Regional & provincial rates Percent positivity Positive test turnaround time Case investigation time

733 views • 46 slides

September 18, 2020 COVID-19 Epidemiological Summary Content covered: Epidemic curves

September 18, 2020 COVID-19 Epidemiological Summary Content covered: Epidemic curves Syndromic surveillance Regional & provincial rates Percent positivity Positive test turnaround time Case investigation time Age

845 views • 42 slides

In-depth epidemiological study of cholera in Zambia Epidemiological study of cholera hotspots and

In-depth epidemiological study of cholera in Zambia Epidemiological study of cholera hotspots and epidemiological basins in East and Southern Africa Kapina M. MD; Dunoyer J. MSc.; Moore S. PhD; Valingot C. MSc.; Kapata N. MD; Sudre B. MD, PhD;

1.62k views • 26 slides

Considerations for COVID-19 Vaccine Prioritization Sarah Mbaeyi, MD MPH June 24, 2020 For more

ACIP COVID-19 Vaccines Work Group Considerations for COVID-19 Vaccine Prioritization Sarah Mbaeyi, MD MPH June 24, 2020 For more information: www.cdc.gov/COVID19 Identifying priority groups for COVID-19 vaccination An essential roadmap for

776 views • 24 slides

ACIP COVID-19 Vaccines Work Group COVID-19 vaccine Work Group Considerations: Evidence to

ACIP COVID-19 Vaccines Work Group COVID-19 vaccine Work Group Considerations: Evidence to Recommendation Framework Kathleen Dooling, MD MPH July 29, 2020 For more information: www.cdc.gov/COVID19 Work Group Considerations: Objectives of the

319 views • 17 slides

The Future of Caribbean Tourism Key Considerations for the COVID-19 recovery Caribbean

The Future of Caribbean Tourism Key Considerations for the COVID-19 recovery Caribbean Tourism Organization April 30, 2020 1 COVID-19 and Caribbean Tourism A quick snapshot 2 COVID-19 Caribbean overview The first cases of COVID-19

834 views • 14 slides

In-depth cholera epidemiological study of Cholera in Zimbabwe Epidemiological study of cholera

In-depth cholera epidemiological study of Cholera in Zimbabwe Epidemiological study of cholera hotspots and epidemiological basins in East and Southern Africa Prospective Cooperation Cholera Team Cholera specialist Bio-statistic specialist

521 views • 27 slides

Phase 1 allocation COVID-19 vaccine: Work Group considerations Kathleen Dooling, MD MPH

ACIP COVID-19 Vaccines Work Group Phase 1 allocation COVID-19 vaccine: Work Group considerations Kathleen Dooling, MD MPH September 22, 2020 For more information: www.cdc.gov/COVID19 Work Group Considerations: Goals of the COVID-19 Vaccine

549 views • 35 slides

COVID-19 vaccine prioritization: Work Group considerations Kathleen Dooling, MD MPH August 26,

ACIP COVID-19 Vaccines Work Group COVID-19 vaccine prioritization: Work Group considerations Kathleen Dooling, MD MPH August 26, 2020 For more information: www.cdc.gov/COVID19 Work Group Considerations: Goals of the COVID-19 Vaccine Program

463 views • 28 slides

Data Sources for Epidemiological Studies Xian Wu Division of Biostatistics and Epidemiology

Data Sources for Epidemiological Studies Xian Wu Division of Biostatistics and Epidemiology Department of Healthcare Policy and Research 10.10.17 1 Agenda for today Scientific and operational considerations involved in planning a

596 views • 43 slides

CONSIDERATIONS FOR RE-OPENING Serving your community in the safest way possible Presented by:

CONSIDERATIONS FOR RE-OPENING Serving your community in the safest way possible Presented by: Centralina Area Agency on Aging May 6, 2020 North Carolina has taken aggressive action to save lives. Policies were put in place to slow the

460 views • 21 slides

In-depth cholera epidemiological study for South Sudan Epidemiological study of cholera hotspots

In-depth cholera epidemiological study for South Sudan Epidemiological study of cholera hotspots and epidemiological basins in East and Southern Africa Presentation for the Cholera Task Force by Prospective Cooperation May, 2018 Prospective

494 views • 20 slides

Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines Doran

Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines Doran Fink, MD, PhD FDA/CBER Office of Vaccines Research and Review ACIP COVID-19 Meeting July 29, 2020 FDA Licensure Requirement for demonstration of

772 views • 8 slides

COVID-19 vaccine prioritization: Work Group considerations Sarah Mbaeyi, MD MPH July 29, 2020

ACIP COVID-19 Vaccines Work Group COVID-19 vaccine prioritization: Work Group considerations Sarah Mbaeyi, MD MPH July 29, 2020 For more information: www.cdc.gov/COVID19 Identifying priority groups for COVID-19 vaccination Importance of

463 views • 32 slides

ACIP COVID-19 Vaccines Work Group Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical

ACIP COVID-19 Vaccines Work Group Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations Sarah Mbaeyi, MD MPH December 12, 2020 For more information: www.cdc.gov/COVID19 Clinical considerations for use of Pfizer-BioNTech COVID-19

803 views • 32 slides

Pharmacotherapy Considerations in Hemodialysis-Required Patients with COVID-19 By: Dr. Yunes

Pharmacotherapy Considerations in Hemodialysis-Required Patients with COVID-19 By: Dr. Yunes Panahi Fellowship of Critical Care Pharmacotherapy Pharmacokinetic Considerations Pharmacokinetic Considerations in Hemodialysis Uremic patients

426 views • 27 slides

Transplant Pharmacotherapy Considerations in Patients with COVID-19 Dr.Yunes Panahi Professor

Transplant Pharmacotherapy Considerations in Patients with COVID-19 Dr.Yunes Panahi Professor &Fellowship of critical care pharmacotherapy May 2020 People at high risk for severe COVID 19: Immuno-compromised patients: Patient who

334 views • 22 slides

II Timothy 3:16-4:5 Opening Considerations: Worldview affects our understanding of masculinity.

II Timothy 3:16-4:5 Opening Considerations: Worldview affects our understanding of masculinity. Progressive ideologies are seeking to eradicate traditional masculinity from our society. While the meathead man ought not be desired,

155 views • 4 slides

Adults with IDD & COVID 19 Special considerations for infection prevention, control and

Adults with IDD & COVID 19 Special considerations for infection prevention, control and management for this vulnerable population (PONDA Meeting May 8, 2020) Dr. Liz Grier, MD, CCFP Senior Advisor, Developmental Disabilities, Department

261 views • 11 slides

Key Clinical Research Considerations During the COVID-19 Pandemic: A Trialists Perspectives

Key Clinical Research Considerations During the COVID-19 Pandemic: A Trialists Perspectives Deepak L. Bhatt, MD, MPH Executive Director of Interventional Cardiovascular Programs, Brigham and Womens Hospital Heart and Vascular Center

459 views • 14 slides